These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 3095199

  • 1. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Samama M, Horellou MH, Nguyen G, Conard J.
    Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
    [No Abstract] [Full Text] [Related]

  • 2. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 3. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
    Sherry S.
    Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thrombolytic treatment in acute myocardial infarction.
    Acar J, Vahanian A, Michel PL, Slama M, Cormier B, Roger V.
    Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Thrombolytic therapy in acute myocardial infarct].
    Bode C, Baumann H, von Hodenberg E, Kübler W.
    Med Klin (Munich); 1992 Feb 15; 87(2):64-9. PubMed ID: 1542285
    [No Abstract] [Full Text] [Related]

  • 11. Modern strategies for treatment of acute myocardial infarction: significance of haemostaseological and rheological findings.
    Pindur G, Sen C, Wenzel E, Jung F, Ozbek C, Schwerdt H, Schieffer H, Bette L, Miyashita C.
    Adv Exp Med Biol; 1990 Feb 15; 281():389-94. PubMed ID: 2129376
    [Abstract] [Full Text] [Related]

  • 12. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D, Bounameaux H.
    Herz; 1986 Feb 15; 11(1):9-15. PubMed ID: 3082731
    [Abstract] [Full Text] [Related]

  • 13. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP, Hanssen M.
    Drugs; 1987 Feb 15; 33 Suppl 3():247-52. PubMed ID: 2445540
    [Abstract] [Full Text] [Related]

  • 14. On the fibrinolytic and thrombolytic properties of active-site p-anisoylated streptokinase-plasminogen complex (BRL 26921).
    Matsuo O, Collen D, Verstraete M.
    Thromb Res; 1981 Nov 15; 24(4):347-58. PubMed ID: 7038976
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Thrombolytics and their use].
    Alessi MC, Juhan-Vague I.
    Rev Prat; 1999 Oct 01; 49(15):1654-8. PubMed ID: 10581996
    [Abstract] [Full Text] [Related]

  • 17. [New thrombolytic agents].
    Nguyen G, Samama M.
    Ann Biol Clin (Paris); 1987 Oct 01; 45(2):212-8. PubMed ID: 3113300
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Oct 01; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.